These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24899100)
1. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo. Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100 [TBL] [Abstract][Full Text] [Related]
2. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth. Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo. Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo. Li M; Li Z; Liang C; Han C; Huang W; Sun F Oncol Rep; 2014 Nov; 32(5):2183-90. PubMed ID: 25174621 [TBL] [Abstract][Full Text] [Related]
5. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels. Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells. Zhang W; Du Y; Jiang T; Geng W; Yuan J; Zhang D Mol Med Rep; 2015 Aug; 12(2):2919-25. PubMed ID: 25955394 [TBL] [Abstract][Full Text] [Related]
7. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo. Wang T; Yan XB; Zhao JJ; Ye J; Jiang ZF; Wu DR; Xiao WH; Liu RY Lung Cancer; 2011 Jun; 72(3):287-93. PubMed ID: 21040996 [TBL] [Abstract][Full Text] [Related]
8. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling. Wu N; Hui H; Cui L; Yang F Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo. Pan Y; Zhang L; Zhang X; Liu R Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630 [TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo. Wen LJ; Gao LF; Jin CS; Zhang HJ; Ji K; Yang JP; Zhao XJ; Wen MJ; Guan GF Int J Clin Exp Pathol; 2013; 6(10):2071-81. PubMed ID: 24133585 [TBL] [Abstract][Full Text] [Related]
11. Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth. Liu YB; Zhang L; Guo YX; Gao LF; Liu XC; Zhao LJ; Guo BF; Zhao LJ; Zhao XJ; Xu DQ Asian J Androl; 2012 Jul; 14(4):536-45. PubMed ID: 22580637 [TBL] [Abstract][Full Text] [Related]
12. Cao F; Zhang Q; Chen W; Zheng F; Ran Q; He Y; Gao Y; Yao S Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074558 [TBL] [Abstract][Full Text] [Related]
13. Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways. Ren M; Wang Y; Wu X; Ge S; Wang B J Drug Target; 2017 Mar; 25(3):247-254. PubMed ID: 27677346 [TBL] [Abstract][Full Text] [Related]
14. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis. Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605 [TBL] [Abstract][Full Text] [Related]
16. The effect of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) on STAT3-induced gene expression in renal carcinoma. Cui L; Meng Q; Wen J; Yan Z; Gao Z; Tian Y; Xu P; Lian P; Yu H J Biochem; 2018 Oct; 164(4):285-294. PubMed ID: 29961871 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer. Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343 [TBL] [Abstract][Full Text] [Related]
18. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity. Nallar SC; Kalakonda S; Sun P; Ohmori Y; Hiroi M; Mori K; Lindner DJ; Kalvakolanu DV Am J Pathol; 2010 Aug; 177(2):896-907. PubMed ID: 20595633 [TBL] [Abstract][Full Text] [Related]
19. GRIM-19 in Health and Disease. Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812 [TBL] [Abstract][Full Text] [Related]
20. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis. Zhang J; Chu D; Kawamura T; Tanaka K; He S J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]